Interpace Biosciences (OTC: IDXG)
$1.50
(5.4%)
$0.08
Price as of April 26, 2024, 3:52 p.m. ET
Interpace Biosciences Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Interpace Biosciences Company Info
Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test, ThyGenX, an expanded oncogenic mutation panel that helps identify malignant thyroid nodules, ThyraMIR, which assesses thyroid nodules for risk of malignancy, and RespriDx, a genomic test that helps physicians differentiate metastatic or recurrent lung cancer. The company was founded by John P. Dugan in 1986 and is headquartered in Parsippany, NJ.
News & Analysis
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.